Several critical research gaps remain
Be cautious with methylated supplements they can worsen symptoms
Tirzepatide showed up to 20% weight loss in obese individuals and significant HbA 1c reduction in type 2 diabetes patients
A narrative review of glutathione supplementation reported that 37.5 percent of participants receiving 1.2 g of glutathione twice weekly for six weeks experienced temporary lightening, yet benefits faded within six months, and 32 percent experienced adverse events such as liver dysfunction or anaphylaxis
Inflammation research : official journal of the European Histamine Research Society [et al] 73:160114
So when they looked at age, baseline weight, type two diabetes, behavioral support, dietician support, that didn't have an impact, so accounting for all of that, the people in hormone replacement therapy still had better intended outcomes, which the intention was to lose weight